Pars Isotope in EANM timelines Our 13th participation in the most…
Follow Us:
Follow The Variety this year in Hamburg introducing diverse and practical…
Updating of the general catalogue of pharmaceutical products (general) The general…
The members of the Program, Budget and Accounting Commission of the…
Image of the Month in the European Journal of Nuclear Medicine:…
A report on how to perform Process imaging in Tc-99m-Trodat radiopharmaceutical…
CEO of Pars Isotope at the BRICS 2024: Paying attention to…
A visual report of the first scientific symposium and gathering of…
The presence of Pars Isotope at the 17th International Breast Cancer…
CEO of Pars Isotope: We are moving on the frontier of…
Pars Isotope wishes all foreign business partners and colleagues a very…
The presence of Pars Isotope in the 24th Iranian Nuclear Medicine…
A meeting with the presence of nuclear medicine centers equipped with…
Pictures and news report of Pars Isotope’s presence at the 29th…
Holding a preclinical imaging conference With the special participation of Pars…
The Spanish Version of Pars Isotope’s website has been launched The…
The presence of Pars Isotope in the 29th Congress of the…
The presence of Pars Isotope in the Annual EANM Congress Pars…
Pictures and news reports from the Pars Isotope booth at the…
Presence of Pars Isotope Co. at the SASNM congress in South…
The new phantom manufactured by Pars Isotope Co. received approval from…
Obtaining a bilingual GMP certificate from Iran Food and Drug Administration…
Presence of Pars Isotope in the 6th International Cancer Congress Pars…
The presence of Pars Isotope Co. in International Symposium on Trends…
The presence of Pars Isotope in the international health exhibition of…
The Administrator of Drug and Controlled Substances Affairs of the Food…
Utilizing radiopharmaceuticals made by Pars Isotope Co. for the feasibility and…
Production of Pars-GalluGEN generator with the maximum amount of output activity…
Utilizing radiopharmaceuticals; prosperity of health diplomacy “Radiopharmaceutical technology is the prosperity…
Synthesis of the active ingredient of MDP radiopharmaceutical kit by Pars…
Photo album of Pars Isotope’s participation at the EANM 2022 exhibition…
Updates on Pars Isotope’s Pharmaceutical Products Catalog The latest catalog of…
The new version of Pars Isotope’s radiopharmaceutical kits catalog The latest…
Waving Pars Isotope’s Flag atop Mount Ararat Peak On August 8,…
The SNMMI 2022 International Best Abstract Award for Iran Abstract submitted…
The UN Special Rapporteur Paid a Visit to Pars Isotope .Co…
One-day seminar on “The role of radiopharmaceuticals in the diagnosis and…
One-day Seminar on The Role of Radiopharmaceuticals in the Diagnosis and…
Unveiling of Pars Isotope’s latest products at the National Nuclear Technology…
The US Food and Drug Administration (FDA) Approves the Lu-177-PSMA Radiopharmaceutical…
The Head of the National Cancer Research Center visited Pars Isotope…
Renewal of GMP certificate for production lines of Pars Isotope radiopharmaceutical products by IFDA
Renewal of GMP certificate for production lines of Pars Isotope radiopharmaceutical…
The managers and news editors of IRIB made a visit to…
Inauguration of Nuclear Medicine Department of Shahriar Specialized and Sub-Specialized Hospital…
Tc-99m-PSMA SPECT/CT Versus Ga-68-PSMA PET/CT in the Evaluation of Metastatic Prostate…
Pars Isotope supports the fifth “Iranian Particle Accelerator Conference” Pars Isotope…
The interview of IRINN Channel with parsisotope’s experts Production of more…
The Head of Atomic Energy Organization of Iran made an official…
Participation of Pars Isotope in the 34th European Nuclear Medicine Exhibition…
The guests of the International Islamic Unity Conference had a visit…